NFKB1 and colorectal carcinoma: As in many other tumors, in CRC, mutations which may occur in the p53 gene may disrupt the activity of NF-κB. In one study, the rate of p53 overexpression was as high as 73% in primary CRC and 66% in distant metastases [25].